Puma Biotechnology (PBYI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 63,913 | 71,981 | 72,797 | 98,698 | 104,503 |
| Marketable Securities | 9,994 | 18,975 | 23,596 | 19,127 | 13,397 |
| Receivables | 27,039 | 32,526 | 23,799 | 30,549 | 26,158 |
| Inventories | 7,277 | 7,109 | 7,206 | 7,620 | 7,745 |
| Other current assets | 631 | 447 | 451 | 478 | 373 |
| TOTAL | $117,570 | $140,022 | $136,923 | $167,751 | $163,765 |
| Non-Current Assets | |||||
| PPE Net | 1,591 | 1,756 | 1,924 | 2,099 | 2,283 |
| Intangibles | 64,121 | 66,125 | 68,129 | 70,133 | 72,136 |
| Other Non-Current Assets | 17,403 | 18,682 | 19,311 | 20,015 | 20,475 |
| TOTAL | $83,115 | $86,563 | $89,364 | $92,247 | $94,894 |
| Total Assets | $200,685 | $226,585 | $226,287 | $259,998 | $258,659 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 31,429 | 22,857 |
| Accounts payable and accrued liabilities | 7,412 | 11,174 | 20,047 | 11,166 | 10,654 |
| Accrued Expenses | 61,837 | 92,575 | 90,782 | 88,601 | 100,585 |
| Other current liabilities | 1,842 | 2,263 | 1,978 | 3,368 | 3,092 |
| TOTAL | $74,789 | $109,586 | $116,261 | $137,900 | $140,408 |
| Non-Current Liabilities | |||||
| Long Term Debt | 97,381 | 97,092 | 96,802 | 68,706 | 76,346 |
| Other Non-Current Liabilities | 21,370 | 22,353 | 24,146 | 23,923 | 25,468 |
| TOTAL | $118,751 | $119,445 | $120,948 | $92,629 | $101,814 |
| Total Liabilities | $193,540 | $229,031 | $237,209 | $230,529 | $242,222 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 44,973 | 41,333 | 40,886 | 40,779 | 40,362 |
| Common Shares | 4 | 4 | 4 | 4 | 4 |
| Retained earnings | -1,370,160 | -1,366,757 | -1,370,981 | -1,326,309 | -1,321,103 |
| Other shareholders' equity | -1 | -2 | -2 | -1 | 0 |
| TOTAL | $7,145 | $-2,446 | $-10,922 | $29,469 | $16,437 |
| Total Liabilities And Equity | $200,685 | $226,585 | $226,287 | $259,998 | $258,659 |